Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Genetic Epidemiology of Early-Onset Alzheimer's disease in Caribbean Hispanics and non-Hispanic Whites.
Resource for Early-onset Alzheimer Disease Research (READR),
Enrolling:Male and Female Patients
Clinic Visits:1
Age Range:Between 70 and 101 years old
IRB Number:AAAQ9793
U.S. Government ID:NCT04906863
Contact: Penelope Baez: 212-305-1527 /
Additional Study Information:

We are recruiting families or individuals with members above the age of 70 who do not have dementia or are not experiencing memory problems. Our initial screening can be completed in person or over the phone. The evaluation will take about 1 to1.5 hours per person and includes a: 1. Blood sample (5 tablespoons) or saliva (1 teaspoon) collection: These blood samples will allow us to examine genes to identify causative mutations. 2. Brief Neuropsychological Assessment. 3. Medical History: A research physician will collect basic medical information on you and your family. This assessment will provide information on other risk factors that could be potentially associated with Early Onset Alzheimer's Disease susceptibility. NOTE: Due to the COVID-19 pandemic, we are currently completing large parts of these assessments through video conferencing (Zoom). Zoom is confidential and HIPPA compliant. Once the pandemic subsides we will resume in-person assessments.

Do You Qualify?
Do you have memory problems that began before the age of 65?YesNo
Do you have a family history of memory loss?YesNo
Do you have any other living family members with memory loss?YesNo
Have you or any other family members been diagnosed with Frontotemporal Dementia?YesNo
Have you or any other family members been diagnosed with Lewy Body Disease?YesNo
Christiane Reitz, MD, PhD
You may be eligible for this study

Place Holder

Who Can I Contact?
For more information, please contact:
Penelope Baez
Phone: 212-305-1527